NRGBiotic

CLINICAL TRIAL

A randomised placebo controlled clinical trial investigating the role of a combination of probiotics and magnesium orotate for the management of depression.

FORMULATION

NRGBiotic™ is a patented formulation created by Medlab Clinical’s researchers to positively influence mood disorders such as anxiety and depression. NRGBiotic™ promotes these effects by shifting the intestinal microbiome that, with the addition of other compounds re-establishes a neuroendocrine immunological balance in the gut between the intestines and the brain. NRGBiotic™ contains Magnesium Orotate and Coenzyme Q10 together with three probiotic genera.

DATE of HREC approval

  • UQ HREC: 22/03/2017
  • QUT HREC: 30/04/18

HREC

  1. University of Queensland Human Research Ethics Committee A Registration, EC00456
  2. QUT Office of Research Ethics & Integrity, EC00171

HREC Approval ID

  1. UQ HREC | 2017000186
  2. QUT HREC | 700001111

CTN

CT- CT-2017-CTN-01080-1 v3

ANZCTR

ACTRN12617000419369

STUDY SITE

Queensland University of Technology

STATUS

Recruiting open

PUBLICATIONS

  • Vitetta L, Bambling, M, Alford H. The gastrointestinal tract microbiome, probiotics and mood. Inflammopharmacology 2014; doi:10.1007/s10787-014-0216-x.